|
CN111655206A
|
|
Fluid exchange device for expandable port delivery system and method of use
|
|
KR20180133440A
|
|
Transplantable ophthalmic drug delivery device
|
|
KR20180084104A
|
|
Porous structures for extended release drug delivery devices
|
|
KR20170106298A
|
|
Expandable drug delivery devices and methods of use
|
|
MX2017001818A
|
|
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
|
|
BR112017000774A2
|
|
eye implant delivery device and method
|
|
WO2015085234A1
|
|
Implantable therapeutic devices
|
|
AU2014202463A1
|
|
Combined drug delivery methods and apparatus
|
|
WO2014160884A1
|
|
Ophthalmic implant for delivering therapeutic substances
|
|
AU2014236455A1
|
|
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US2013218081A1
|
|
Pharmaceutical Delivery Device and Method for Providing Ocular Treatment
|
|
WO2013116061A1
|
|
Insertion and removal methods and apparatus for therapeutic devices
|
|
CA2848385A1
|
|
Methods and apparatus to exchange a fluid of an implantable device
|
|
WO2013022801A1
|
|
Small molecule delivery with implantable therapeutic device
|
|
WO2013003620A2
|
|
Diagnostic methods and apparatus
|
|
WO2012068549A2
|
|
Therapeutic agent formulations for implanted devices
|
|
WO2012065006A2
|
|
Methods and apparatus to determine diffusion properties of porous structures for drug delivery
|
|
CN103153316A
|
|
Combined drug delivery methods and apparatus
|
|
AU2011285501A1
|
|
Implantable therapeutic device
|
|
EP2600920A2
|
|
Subconjunctival implant for posterior segment drug delivery
|
